The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia
Abstract
Oxytocin has numerous prosocial and antipsychotic-like effects in animals. Prosocial effects of acute intranasal oxytocin administration have also been reported in human subjects. We conducted a randomized, placebo-controlled trial testing the effects of twice daily intranasal oxytocin treatment for 14 days on psychotic symptoms and social cognition in patients with schizophrenia. PANSS scores declined significantly and several social cognition measures improved significantly or nearly significantly in oxytocin (N=11) but not placebo (N=9) recipients. Our results suggest that, in addition to reducing classic psychotic symptoms, oxytocin may diminish certain social cognition deficits that are not improved by current antipsychotic medications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The acute effects of intranasal OT that we found here resemble those found in many human studies, consisting of an increase in pro-social behavior and engagement (specifically time spent in contact in males)(13,15,64–66).”
From Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles (2013) · cites this paper as [15]
In the citing paper
“while some studies among patients with other psychiatric disorders (e.g., autism, alcohol use disorder) have utilized a repeated dosing strategy in the form of 1–3 daily doses, most of these studies are only 8 days or less (Dadds et al., 2014; Guastella et al., 2015; Pedersen et al., 2011).”
From Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial (2018) · cites this paper as Pedersen et al., 2011
In the citing paper
“Safety and feasibility of daily dosing has been demonstrated in other human OT studies including those with alcohol-dependent patients (Pedersen et al., 2013), patients with schizophrenia (Pedersen et al., 2011) and individuals with trauma exposure (van Zuiden et al., 2016).”
From Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial (2018) · cites this paper as Pedersen et al., 2011
In the citing paper
“Support for the notion that an effect size of d = 0.4 adequately reflects the potential of oxytocin to reduce psychiatric symptoms stems from 2 previous studies on long-term intranasal oxytocin administration in the treatment of positive and negative symptoms in schizophrenia patients [61,97].”
From Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial (2014) · cites this paper as [97]
In the citing paper
“The observed effect sizes were between d = 0.05 - 0.88 [97] and d = 0.24 -.74 (for most outcomes around d = 0.4) [61], depending on the outcome measure.”
From Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial (2014) · cites this paper as [97]
In the citing paper
“Noteworthy, oxytocin treatment greatly reduced anxiety symptoms in schizophrenic patients (d = 0.62) [97].”
From Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial (2014) · cites this paper as [97]
In the citing paper
“Previous research has shown modest effects of OT on people suffering from social deficits, such as autism spectrum disorders (Hollander et al., 2007), schizophrenia (Pedersen et al., 2011) or social anxiety disorder (Guastella et al., 2009).”
From OT promotes closer interpersonal distance among highly empathic individuals (2015) · cites this paper as Pedersen et al., 2011
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Frith, C., & Frith, U. (2005) · Current Biology · doi:10.1016/j.cub.2005.08.041 · Cited by 3,561
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089
Fett, A.-K. J., Viechtbauer, W., Dominguez, M.-D.-G., Penn, D. L., van Os, J., & Krabbendam, L. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.001 · Cited by 1,833
The Functional Significance of Social Cognition in Schizophrenia: A Review
Couture, S. M. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl029 · Cited by 1,363
Sniffing neuropeptides: A transnasal approach to the human brain
Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356
The human amygdala in social judgment
Adolphs, R., Tranel, D., & Damasio, A. R. (1998) · Nature · doi:10.1038/30982 · Cited by 1,125
Oxytocin: The Great Facilitator of Life
Lee, H.-J., Macbeth, A. H., Pagani, J., & Young, W. S. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.001 · Cited by 1,037
The Human Amygdala in Social Judgment
Adolphs, R., Tranel, D., & Damásio, A. R. (2002) · The MIT Press eBooks · doi:10.7551/mitpress/3077.003.0027 · Cited by 881
Paranoia and self-consciousness.
Fenigstein, A., & Vanable, P. (1992) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.62.1.129 · Cited by 643
Flagged first, then by citations
1 of the 29 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 305
Haram, M., Tesli, M., Dieset, I., Steen, N. E., Røssberg, J. I., Djurovic, S., Andreassen, O. A., & Melle, I. S. (2014) · Neuropsychobiology · doi:10.1159/000356965 · Cited by 14
Challenges in the Development and Application of Organ-on-Chips for Intranasal Drug Delivery Studies
Khan, M. U., Cai, X., Shen, Z., Mekonnen, T. T., Kourmatzis, A., Cheng, S., & Gholizadeh, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051557 · Cited by 14
Pedersen, C. A. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.050 · Cited by 11
Pierce, M. L., Mehrotra, S., Mustoe, A. C., French, J. A., & Murray, T. F. (2019) · Molecular Pharmacology · doi:10.1124/mol.118.114744 · Cited by 12
Women and schizophrenia: new findings
Seeman, M. V. (2013) · Neuropsychiatry · doi:10.2217/npy.13.55 · Cited by 12
Differential effects of oxytocin on mouse hippocampal oscillations in vitro
Maier, P., Kaiser, M. E., Grinevich, V., Draguhn, A., & Both, M. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13412 · Cited by 12
Effects of Oxytocin on Emotion Recognition in Schizophrenia
Andari, E., Massa, N., Fargotstein, M., Taylor, N. B., Halverson, D. M., Owens, A. V., Currin, D. L., Bhattacharya, A., Gitman, D., Cuthbert, B. C., et al. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001367 · Cited by 14
Thorson, K. R., McKernan, S. M., West, T. V., Woolley, J. D., Mendes, W. B., & Stauffer, C. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-99957-8 · Cited by 12
Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator
Hoirisch-Clapauch, S., & Nardi, A. E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126053 · Cited by 12
Pek, T. M., Yazıcı, E., Güzel, D., Köse, E., Yazıcı, A. B., & Erol, A. (2019) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2019.1653149 · Cited by 11
International perspective on social cognition in schizophrenia: current stage and the next steps
Corbera, S., Kurtz, M. M., Achim, A. M., Agostoni, G., Amado, I., Assaf, M., Barlati, S., Bechi, M., Cavallaro, R., Ikezawa, S., et al. (2025) · European Psychiatry · doi:10.1192/j.eurpsy.2024.1776 · Cited by 14
Exploring a Possible Interplay between Schizophrenia, Oxytocin, and Estrogens: A Narrative Review
Papadea, D., Dalla, C., & Tata, D. Α. (2023) · Brain Sciences · doi:10.3390/brainsci13030461 · Cited by 12
Evaluating self- vs. other-owned objects: The modulatory role of oxytocin
Wu, Y., van Dijk, E., & Zhou, X. (2012) · Biological Psychology · doi:10.1016/j.biopsycho.2012.11.011 · Cited by 12
The effect of oxytocin on group formation and strategic thinking in men
Aydogan, G., Jobst, A., Loy, F., Dehning, S., Zill, P., Müller, N., & Kocher, M. G. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.02.003 · Cited by 13
Hazani, R., Michal Lavidor, B., & Weller, A. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac093 · Cited by 8
Effects of mind-body therapies on schizophrenia: A systematic review and network meta-analysis
Su, Y., Pan, X., Li, H., & Zhang, G. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2023.12.030 · Cited by 9
DNA damage after chronic oxytocin administration in rats: a safety yellow light?
Leffa, D. D., Daumann, F., Damiani, A. P., Afonso, A. D. C., dos Santos, M. A. B., Pedro, T. H., de Souza, R. P., & de Andrade, V. M. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9885-z · Cited by 9
Kampka, N., Frommann, N., Henning, U., Schwark, R., Wölwer, W., Pietrowsky, R., & Luckhaus, C. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1955-4 · Cited by 9
Personality Disorders, Attachment and Psychodynamic Psychotherapy
Weinstein, L., Pérez-Rodríguez, M. M., & Siever, L. J. (2014) · Psychopathology · doi:10.1159/000366135 · Cited by 7
Flanagan, J. C., Mitchell, J., Baker, N. L., Woolley, J. D., Wangelin, B. C., Back, S. E., McQuaid, J. R., Neylan, T. C., Wolfe, W. R., & Brady, K. T. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.106074 · Cited by 10
Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review
Arsenault‐Mehta, K., Hochman‐Bérard, M., Johnson, A., Semenova, D., Nguyen, B., Willis, J. V., Mouravska, N., Joober, R., & Zhand, N. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12382 · Cited by 8
Judging Strangers’ Trustworthiness is Associated with Theory of Mind Skills
Prévost, M., Brodeur, M. B., Onishi, K. H., Lepage, M., & Gold, I. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00052 · Cited by 9
The Use of Oxytocin in Personality Disorders: Rationale and Current Status
Pérez-Rodríguez, M. M., Derish, N. E., & New, A. S. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0026-1 · Cited by 8
Going From Social Neuroscience to Schizophrenia Clinical Trials
Green, M. F., & Penn, D. L. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt128 · Cited by 8
Repurposed Drugs for the Treatment of Schizophrenia and Bipolar Disorders
Bumb, J. M., Enning, F., & Leweke, F. M. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660165 · Cited by 7
The Efficacy of Animal-Assisted Therapy in Patients with Dual Diagnosis: Schizophrenia and Addiction
Monfort, M., Benito, A., Haro, G., Fuertes-Sáiz, A., Cañabate, M., & Baquero, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116695 · Cited by 7
Lin, C., Zhuo, S., Zheng, Q., Li, X., & Peng, W. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114266 · Cited by 7
Simon-Dack, S. L., & Marmarosh, C. L. (2014) · Journal of Counseling Psychology · doi:10.1037/cou0000020 · Cited by 7
Modeling Schizophrenia in Animals
Feifel, D., & Shilling, P. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00030-0 · Cited by 8
Zanos, P., Keyworth, H. L., Georgiou, P., Hambsch, B., Otte, D. M., Kitchen, I., Zimmer, A., & Bailey, A. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14155 · Cited by 7
Zhao, W., Zhang, X., & Kendrick, K. M. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106624 · Cited by 7
Case Report: Oxytocin and Its Association With Psychotherapy Process and Outcome
Grossman‐Giron, A., Bitan, D. T., Zilcha‐Mano, S., Nitzan, U., Mendlovic, S., & Maoz, H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.691055 · Cited by 6
Paliperidone Compared with Haloperidol on the Theory of Mind Tasks in Schizophrenia: A Pilot Trial
Zhong, J., Hong, Z., Yin, D., Ning, Y., Zheng, S., Zhang, Y., & Jia, H. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s335597 · Cited by 6
Functional implications and course
Harvey, P. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.006 · Cited by 6
Oxytocin: an expansive review of its mechanisms, functions, and therapeutic potential
Ueda, Y. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.19.1.1499 · Cited by 5
The Role of Lactylation in Mental Illness: Emphasis on Microglia
Sfera, A., Klein, C. A., Anton, J. J., Kozlakidis, Z., & Andronescu, C. V. (2023) · Neuroglia · doi:10.3390/neuroglia4020009 · Cited by 5
Sun, W., Jin, T., Yang, H., Li, J., Tian, Q., Gao, J., Peng, R., Zhang, G., & Zhang, X. (2024) · Schizophrenia · doi:10.1038/s41537-023-00425-1 · Cited by 3
Oxytocin in Prevention of Schizophrenia
Tadjibaev, A. (2013) · International Journal of Prevention and Treatment of Substance Use Disorders · Cited by 4
Oxytocin administration versus emotion training in healthy males: considerations for future research
Daughters, K., Rees, A., Hunnikin, L. M., Wells, A. E., Hall, J., & van Goozen, S. H. M. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0056 · Cited by 3
Remédiation cognitive dans la schizophrénie et les troubles apparentés en pratique quotidienne
Péneau, E., & Nicolas Franck, B. (2015) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2015.02.002 · Cited by 4
Therapeutic Considerations in Individuals at Clinical Risk for Developing Psychosis
Singh, F., DeJoseph, M. L., & Cadenhead, K. S. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0009-2 · Cited by 4
Neurobiological Underpinnings of Empathy
Pan, Y., Liu, Y., Ma, J., Ran, G., & Lei, H. C. (2013) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2012.02011 · Cited by 4
Add-on Oxytocin in the Treatment of Postpartum Acute Schizophrenia: A Case Report
Medved, S., Janović, M. B., Štimac, Z., & Mihaljević-Peleš, A. (2021) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000557 · Cited by 4
Cagna, F. D., Fusar‐Poli, L., Damiani, S., & Mori, A. (2018) · doi:10.26226/morressier.5b681764b56e9b005965c55b · Cited by 4
Pierce, M. L., French, J. A., & Murray, T. F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109832 · Cited by 3
Doshi, G., Bhatia, N. Y., Ved, H. S., Pandya, A., Kulkarni, D., Naik, J., Bandiwadekar, T., Godad, A. P., & Kale, P. P. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220817161035 · Cited by 3
Sampedro-Viana, D., Cañete, T., Ancil-Gascón, P., Cisci, S., Tobeña, A., & Fernández‐Teruel, A. (2024) · Brain Sciences · doi:10.3390/brainsci14090920 · Cited by 3
Novel pharmacotherapy targeting the positive symptoms of schizophrenia
Capuzzi, E., Caldiroli, A., Quitadamo, C., Butturini, F., Surace, T., Clerici, M., & Buoli, M. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2231346 · Cited by 4
The role of the oxytocin system in the resilience of patients with breast cancer
Liu, S., Huang, R., Li, A., Yu, S., Yao, S., Xu, J., Tang, L., Li, W., Chen, G., & Cheng, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1187477 · Cited by 3
İmamoğlu, A., Stiles, B. J., Jarskog, L. F., Pedersen, C. A., Elliott, T., & Penn, D. L. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.01.019 · Cited by 3
Social cognition and its relationship to neurocognition
Pinkham, A. E. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.009 · Cited by 3
Holka-Pokorska, J., & Jarema, M. (2014) · Psychiatria Polska · doi:10.12740/pp/18377 · Cited by 3
Oksitosin ve Psikiyatrik Bozukluklar
Say, G. N., & Müjdeci, M. (2016) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.17749 · Cited by 5
Clinical convergence of autism, schizophrenia, and Alzheimer’s disease: The case of social cognition
Levine, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814037-6.00002-1 · Cited by 3
Saporta, L., Feldman, R., Levi, L. W., Davidson, M., Burshtein, S., Gur, R. C., Zagoory‐Sharon, O., Amiaz, R., Park, J., Davis, J. M., et al. (2024) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgae022 · Cited by 2
The Interplay of Oxytocin and Attachment in Schizophrenic Patients: An fMRI Study
Hennig-Fast, K., Meissner, D., Steuwe, C., Dehning, S., Blautzik, J., Eilert, D. W., Zill, P., Müller, N., Meindl, T., Reiser, M., et al. (2023) · Brain Science · doi:10.3390/brainsci13081125 · Cited by 2
Neumann, I. D. (2012) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00672.x · Cited by 2
Can Oxytocin Enhance Social Affiliation in Schizophrenia?
Bhat, I., Buckner, A., & Ara, A. (2016) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-016-0080-7 · Cited by 2
Oxytocin, trust and very late‐onset schizophrenia‐like psychosis
Bhome, R., & Howard, R. J. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4520 · Cited by 2
Williams, D. R., & Bürkner, P. (2017) · British Journal of Clinical Psychology · doi:10.1111/bjc.12130 · Cited by 2
Yan, Z., & Kirsch, P. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108770880.018 · Cited by 2
Manual and automatic measures confirm — Intranasal oxytocin increases facial expressivity
Neubauer, C. E., Mozgai, S., Chuang, B., Woolley, J. D., & Scherer, S. J. (2017) · International Conference on Affective Computing and Intelligent Interaction and workshops · doi:10.1109/acii.2017.8273605 · Cited by 2
Intranasal oxytocin and its rapidly expanding role in psychiatry
Kapoor, S. N. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.10.013 · Cited by 2
Sağlığın Geliştirilmesinde Hayvan Destekli Uygulamaların Rolü
Dost, A., Gencer, S., Yaşar, S., Korkmaz, Z., & Doğru, R. N. (2023) · Halk Sağlığı Hemşireliği Dergisi · doi:10.54061/jphn.1222502 · Cited by 1
The Social Brain is a Complex Super-Network
Waterhouse, L. H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-415961-7.00003-4 · Cited by 1
Oxytocin, Oxytocin Receptor Genotypes and Social Adaptive Behavior
Nan, W. U., & Yanjie, S. (2013) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2012.00863 · Cited by 1
Self-soothing behaviors with particular reference to oxytocin release induced by non-noxious sensory
Uvnäs‐Moberg, K., Handlin, L., & Petersson, K. M. (2015) · Cited by 1
Savardi, A., Ziogas, I., Bolla, M., & Cancedda, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815318-5.00021-2 · Cited by 1
Experimental Usage of Oxytocin to Combat Deficits in Social Cognition in Schizophrenia
Taş, C., Brown, E. C., Gonzalez, C., & Brüne, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405172-0.00018-1 · Cited by 1
Social Endophenotypes in Mouse Models of Psychiatric Disease
Pisansky, M. T., Gottesman, I. I., & Gewirtz, J. C. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_8 · Cited by 1
Role of oxytocin in social cognition in psychosis spectrum disorders
Benavides, C., Fred-Torres, S., Rutter, S., Larsen, E. M., Fastman, J., Bulbena‐Cabré, A., Lepow, L., Mahon, K., Russo, M., Ungar, A. K., et al. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815315-4.00006-9 · Cited by 1
Kooijmans, E., Fett, A.-K. J., & A, L. K. M. (2014) · Tijdschrift voor Neuropsychiatrie en Gedragsneurologie · doi:10.1007/s40533-014-0004-3
THEORY OF MIND: ASSESSMENT DEVELOPMENT AND INVESTIGATION OF COCAINE DEPENDENTS
Psicologia, M. E. (2014)
Troubles schizophréniques et théorie de l'esprit
Roux, P., Brunet-Gouet, É., & Passerieux, C. (2015) · Time to knit · doi:10.1016/s0246-1072(15)57921-2
Psychosoziale Effekte von Oxytocin und Vasopressin und ihre therapeutischen Anwendungsmöglichkeiten
Thienel, M., & Hallschmid, M. (2012) · Zeitschrift für Medizinische Psychologie · doi:10.3233/zmp-2012-210005
Oksitosin ve Psikiyatrik Bozukluklar Oxytocin and Psychiatric Disorders
Say, G. N., & Müjdeci, M. (2016)
Vingerhoets (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170323wv
Ocitocina, um “medicamento” ainda em potencial terapêutico para distúrbios psiquiátricos
de Deus, D. M. V., & de Freitas, P. S. (2017) · REVISTA HUM@NAE
Oxytocin and epigenetic mechanisms in mouse models of empathy and autism
Pisansky, M. T. (2016) · University of Minnesota Digital Conservancy (University of Minnesota)
The relationship between oxytocin pathway genes and personality traits and psychosis characteristics
Haram, M. (2017) · NORA - Norwegian Open Research Archives
Sun, R. (2017) · Apollo (University of Cambridge) · doi:10.17863/cam.23010 · Cited by 1
Modeling Schizophrenia in Animals
Feifel, D., & Shilling, P. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00023-1
L’ocytocine et la dépression du post-partum
Cardaillac, C., Rua, C., Simon, E. G., & El‐Hage, W. (2017) · Sages-Femmes · doi:10.1016/j.sagf.2017.04.005
Intranasal oxytocin til behandling af Theory of Mind-vanskeligheder hos patienter med skizofreni
Schmidt, L. E. (2019) · Psyke & Logos · doi:10.7146/pl.v40i2.117812
Oxytocin and Social Sensitivity: Implications for Vulnerability to Stress and Depressive Symptoms
McQuaid, R. J. (2015) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2015-11083
Krüeger, F. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108770880.017
Nürnberger, J. I., & Stigler, K. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718052674.793482799
Oxytocin - not only a "social" neuropeptide
Brodmann, K. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5978
Faculty Opinions recommendation of Crystal structure of the human oxytocin receptor.
Freidinger, R. M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738337689.793579103
Moberg, K. U. (2015) · Springer eBooks · doi:10.1007/978-3-662-47359-7_11
Oxytocin, Social Interactions and Coping: Implications for Depression
McInnis, O. A. (2016) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2016-11454
Deep Breath: An Indigenous Healing for Schizophrenia
Dudi, A. K. (2023) · International Journal of Psychiatry Research · doi:10.33425/2641-4317.1179
Más allá de lo habitual: Nuevos enfoques en la terapia de la esquizofrenia resistente
Castellanos, J. F. G., Jiménez, M. R., Bolaños-Chang, A. J., Pelayo, A. M. Z., & Meza, E. A. C. (2023) · Archives of Evidence-Based Medicine · doi:10.59706/aebmedicine.v1i2.9105
Metadata
- Authors
- Pedersen, C. A., Gibson, C. M., Rau, S. W., Salimi, K., Smedley, K. L., Casey, R. L., Leserman, J., Jarskog, L. F., & Penn, D. L.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Pedersen, Cort A.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 132
- Issue
- 1
- Pages
- 50-53
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W1974375338
- Cited by
- 305
- References
- 29
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 8 · 2023: 13 · 2022: 9 · 2021: 18 · 2020: 9 · 2019: 19 · 2018: 17 · 2017: 25 · 2016: 35 · 2015: 36 · 2014: 34 · 2013: 51 · 2012: 23
- FWCI
- 47.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- Funders
- National Institute of Mental Health (R01MH093529)
- National Center for Research Resources (UL1RR025747)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- intranasal oxytocin, schizophrenia
- MeSH terms
- Administration, Intranasal, Adolescent, Adult, Analysis of Variance, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Oxytocin, Psychiatric Status Rating Scales, Psychotic Disorders, Schizophrenia, Schizophrenic Psychology, Social Perception, Antipsychotic Agents, Treatment Outcome, Young Adult, Theory of Mind
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
